Telemedicine for HIV care: a cross-sectional survey of people living with HIV receiving care at two federally qualified health centers in Los Angeles during a mature phase of the COVID-19 pandemic.

Publication date: Dec 31, 2024

The COVID-19 pandemic resulted in the rapid implementation of telemedicine for HIV care at federally qualified health centers (FQHCs) in the United States. We sought to understand use of telemedicine (telephone and video) at two FQHCs in Los Angeles, and the client attitudes towards and experiences with telemedicine as part of future HIV care. We conducted surveys with 271 people living with HIV (PLHIV), with questions covering sociodemographic factors, telemedicine attitudes and experiences, technological literacy, and access to technological resources and privacy. Survey data were analyzed utilizing summary statistics, chi-square analyses, and Fisher’s exact test to understand associations between sociodemographic factors and telemedicine attitudes and experiences. Sixty percent of the sample had used any telemedicine and, of these, 93% utilized only telephone visits. Almost all respondents (95%, n = 257) had access to a functioning smartphone and self-rated their technological literacy as high. Most had consistent access to privacy (88%, n = 239), and those without privacy noted this as a barrier to the use of telemedicine. The main benefits of telemedicine (compared to in person) were savings of time and money, convenience, and ability to complete appointments as scheduled. Just over half of PLHIV said they would feel more comfortable discussing sensitive topics (e. g., substance use, relationship issues) in person than over telephone (60%, n = 164) or video (55%, n = 151). Despite limited experience with video telemedicine, half of all participants desired a mix of telephone and video visits as part of their future HIV care. During a mature phase of the COVID-19 pandemic, PLHIV in our study showed high satisfaction with telemedicine, largely conducted as telephone visits, and high interest in telemedicine visits as a component of their future HIV care. Future studies should explore barriers to implementing video telemedicine in FQHCs and determine telemedicine’s impact on clinical outcomes, including engagement and viral suppression.

Open Access PDF

Concepts Keywords
Comfortable Adult
Covid COVID-19
Federally Cross-Sectional Studies
Hiv Female
Smartphone HIV
HIV Infections
Humans
Los Angeles
Los Angeles
Male
Middle Aged
SARS-CoV-2
Surveys and Questionnaires
Telehealth
Telemedicine
Telemedicine
Young Adult

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH privacy
disease MESH substance use
pathway REACTOME Reproduction
disease MESH Infectious Diseases
disease MESH chronic conditions
drug DRUGBANK Aspartame
disease MESH HIV infections
disease MESH unemployment
disease MESH mental disorders
disease MESH education level
disease MESH viral load
drug DRUGBANK Coenzyme M
disease MESH sinus infection
drug DRUGBANK Etoperidone
disease MESH emergency
disease MESH sexually transmitted infections
disease MESH violence
drug DRUGBANK Trestolone
disease MESH AIDS
drug DRUGBANK Troleandomycin
disease MESH heart failure
disease IDO process
drug DRUGBANK Pentaerythritol tetranitrate
disease IDO intervention
disease MESH Allergy
drug DRUGBANK Terazosin
disease MESH Limited English Proficiency
disease MESH Acute Ischemic Stroke
drug DRUGBANK Acetohydroxamic acid

Original Article

(Visited 1 times, 1 visits today)